FDA inspection
Interojo Inc.: FDA inspection ending Aug 29, 2019
FDA inspection 1101815 · Voluntary Action Indicated (VAI) · Pyeongtaek City
Key facts
| Inspection ID | 1101815 |
|---|---|
| Firm | Interojo Inc. |
| FEI number | 3004146030 |
| Address | 28 25 Sandan-Ro 15 Beon-Gil |
| City | Pyeongtaek City |
| Country | Korea (the Republic of) |
| Fiscal year | 2019 |
| Inspection end date | Aug 29, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data